|
ARHGAP19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37650002507428E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.19470030827074E-10 |
| Normal-vs-Stage2 |
6.26249999999828E-05 |
| Normal-vs-Stage3 |
1.9964999986577E-08 |
| Normal-vs-Stage4 |
1.5500700000004E-05 |
| Stage1-vs-Stage2 |
4.449400E-01 |
| Stage1-vs-Stage3 |
8.979400E-01 |
| Stage1-vs-Stage4 |
7.478800E-01 |
| Stage2-vs-Stage3 |
3.158600E-01 |
| Stage2-vs-Stage4 |
2.912200E-01 |
| Stage3-vs-Stage4 |
7.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66909996934805E-09 |
| Normal-vs-AfricanAmerican |
1.34950000063583E-08 |
| Normal-vs-Asian |
4.816900E-04 |
| Caucasian-vs-AfricanAmerican |
8.419400E-01 |
| Caucasian-vs-Asian |
6.783600E-01 |
| AfricanAmerican-vs-Asian |
6.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69793085042147E-12 |
| Normal-vs-Female |
3.625500E-04 |
| Male-vs-Female |
4.663300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.12420000478275E-08 |
| Normal-vs-Extreme_Weight |
6.66879995669944E-09 |
| Normal-vs-Obese |
2.41569999559488E-08 |
| Normal-vs-Extreme_Obese |
9.76599999757966E-08 |
| Normal_Weight-vs-Extreme_Weight |
9.897800E-01 |
| Normal_Weight-vs-Obese |
3.743200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.063800E-01 |
| Extreme_Weight-vs-Obese |
3.963400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.206990E-01 |
| Obese-vs-Extreme_Obese |
5.385800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.8248000000074E-05 |
| Normal-vs-Age(41-60Yrs) |
2.74429999946868E-07 |
| Normal-vs-Age(61-80Yrs) |
8.47389935998422E-11 |
| Normal-vs-Age(81-100Yrs) |
1.8007000002207E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.823400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.532800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.597500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.085700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.241700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.877200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.24510000485157E-08 |
| Normal-VS-Type2 PRCC |
2.88657986402541E-15 |
| Normal-VS-KIRP CIMP |
1.99859999994167E-07 |
| Normal-VS-Unclassified PRCC |
1.952240E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.177500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.941600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.874400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.356300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.023570E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.613400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92099677778879E-13 |
| Normal-vs-N1 |
2.3130999999954E-05 |
| Normal-vs-N2 |
2.639900E-03 |
| N0-vs-N1 |
7.474200E-02 |
| N0-vs-N2 |
7.804200E-01 |
| N1-vs-N2 |
6.112400E-01 |
|
|
